Patent details

EP2686441 Title: METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN

Basic Information

Publication number:
EP2686441
PCT Application Number:
US2012029479
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127106433
PCT Publication Number:
WO2012129100
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN
French Title of Invention:
PROCÉDÉ ET UTILISATION POUR PRÉDIRE LA RÉPONSE À L'ÉRIBULINE
German Title of Invention:
VERFAHREN UND VERWENDUNGEN ZUR VORHERSAGE DER REAKTION AUF ERIBULIN
SPC Number:

Dates

Filing date:
16/03/2012
Grant date:
08/05/2019
EP Publication Date:
22/01/2014
PCT Publication Date:
27/09/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/05/2019
EP B1 Publication Date:
08/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/03/2020
Expiration date:
16/03/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/05/2019
 
 

Name:
Eisai R&D Management Co., Ltd.
Address:
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Inventor

1

Name:
AGOULNIK, Sergei I.
Address:
United States (US)

2

Name:
LITTLEFIELD, Bruce A.
Address:
United States (US)

3

Name:
BYRNE, Michael Chapman
Address:
United States (US)

Priority

Priority Number:
201161454426 P
Priority Date:
18/03/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/35; G01N 33/574; C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:
201919
Publication date:
08/05/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages